AstroNova, Inc. - Quarter Report: 2021 May (Form 10-Q)

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 1, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number

0-13200

AstroNova, Inc.

(Exact name of registrant as specified in its charter)


Rhode Island		05-0318215
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

600 East Greenwich Avenue, West Warwick, Rhode Island		02893
(Address of principal executive offices)		(Zip Code)

(401)

828-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $.05 Par Value	ALOT	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes

☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes

☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act) Yes ☐ No ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of June 8, 2021 was

7,231,068.

Table of Contents

ASTRONOVA, INC.

INDEX


		Page No.
Part I.	Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets – May 1, 2021 and January 31, 2021		3
	Unaudited Condensed Consolidated Statements of Income — Three Months Ended May 1, 2021 and May 2, 2020		4
	Unaudited Condensed Consolidated Statements of Comprehensive Income — Three Months Ended May 1, 2021 and May 2, 2020		5
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity — Three Months Ended May 1, 2021 and May 2, 2020		6
	Unaudited Condensed Consolidated Statements of Cash Flows — Three Months Ended May 1, 2021 and May 2, 2020		7
	Notes to the Condensed Consolidated Financial Statements (unaudited)		8-20
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		20-29
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		30
Item 4.	Controls and Procedures		30
Part II.	Other Information
Item 1.	Legal Proceedings		30
Item 1A.	Risk Factors		30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		30-31
Item 6.	Exhibits		32
Signatures			33

Table of Contents

Part I. FINANCIAL INFORMATION

Item 1.

Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)


	May 1, 2021			January 31, 2021
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	11,414		$	11,439
Accounts Receivable, net		15,249			17,415
Inventories, net		29,474			30,060
Prepaid Expenses and Other Current Assets		2,072			1,807

Total Current Assets		58,209			60,721
Property, Plant and Equipment, net		12,124			12,011
Intangible Assets, net		20,496			21,502
Goodwill		12,730			12,806
Deferred Tax Assets		5,944			5,941
Right of Use Assets		1,302			1,389
Other Assets		1,251			1,103

TOTAL ASSETS	$	112,056		$	115,473

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	5,639		$	5,734
Accrued Compensation		2,951			2,852
Other Liabilities and Accrued Expenses		3,448			3,939
Current Liability – Royalty Obligation		2,000			2,000
Current Portion of Long-Term Debt		813			5,326
Current Liability – Excess Royalty Payment Due		—			177
Deferred Revenue		330			285
Income Taxes Payable		260			655

Total Current Liabilities		15,441			20,968
Long-Term Debt, net of current portion		8,884			7,109
Royalty Obligation, net of current portion		5,711			6,161
Long-Term Debt – PPP Loan		4,422			4,422
Lease Liabilities, net of current portion		983			1,065
Other Long-Term Liabilities		680			681
Deferred Tax Liabilities		402			384

TOTAL LIABILITIES		36,523			40,790
SHAREHOLDERS’ EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,479,139 shares and 10,425,094 shares at May 1, 2021 and January 31, 2021, respectively		524			521
Additional Paid-in Capital		58,576			58,049
Retained Earnings		50,678			50,085
Treasury Stock, at Cost, 3,312,687 and 3,297,058 shares at May 1, 2021 and January 31, 2021, respectively		(33,796	)		(33,588	)
Accumulated Other Comprehensive Loss, net of tax		(449	)		(384	)

TOTAL SHAREHOLDERS’ EQUITY		75,533			74,683

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	112,056		$	115,473

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Data)

(Unaudited)


	Three Months Ended
	May 1, 2021			May 2, 2020

Revenue	$	29,078		$	30,919
Cost of Revenue		18,190			20,064
Gross Profit		10,888			10,855
Operating Expenses:
Selling and Marketing		6,092			5,925
Research and Development		1,717			1,940
General and Administrative		2,344			2,327
Operating Expenses		10,153			10,192
Operating Income		735			663
Other Expense, net		369			349
Income Before Income Taxes		366			314
Income Tax Benefit		(227	)		(118	)
Net Income	$	593		$	432
Net Income per Common Share—Basic:	$	0.08		$	0.06
Net Income per Common Share—Diluted:	$	0.08		$	0.06
Weighted Average Number of Common Shares Outstanding:
Basic		7,145			7,073
Diluted		7,265			7,105

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)


	Three Months Ended
	May 1, 2021			May 2, 2020

Net Income	$	593		$	432
Other Comprehensive Loss, Net of Taxes:
Foreign Currency Translation Adjustments		(81	)		(142	)
Change in Value of Derivatives Designated as Cash Flow Hedge		—			(46	)
Loss (Gain) from Cash Flow Hedges Reclassified to Income Statement		16			(33	)
Other Comprehensive Loss		(65	)		(221	)
Comprehensive Income	$	528		$	211

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

($ In Thousands, Except per Share Data)

(Unaudited)


	Common Stock				Additional Paid-in			Retained			Treasury			Accumulated Other Comprehensive			Total Shareholders’
	Shares		Amount		Capital			Earnings			Stock			Income (Loss)			Equity
Balance January 31, 2020		10,343,610	$	517	$	56,130		$	49,298		$	(33,477	)	$	(1,093	)	$	71,375
Share-Based Compensation		—		—		495			—			—			—			495
Employee Option Exercises		4,456		—		32			—			—			—			32
Restricted Stock Awards Vested, net		23,638		1		(1	)		—			(54	)		—			(54	)
Common Stock – Cash Dividend - $0.07 per share		—		—		—			(497	)		—			—			(497	)
Net Income		—		—		—			432			—			—			432
Other Comprehensive Loss		—		—		—			—			—			(221	)		(221	)

Balance May 2, 2020		10,371,704	$	518	$	56,656		$	49,233		$	(33,531	)	$	(1,314	)	$	71,562


	Common Stock				Additional Paid-in			Retained		Treasury			Accumulated Other Comprehensive			Total Shareholders’
	Shares		Amount		Capital			Earnings		Stock			Income (Loss)			Equity
Balance January 31, 2021		10,425,094	$	521	$	58,049		$	50,085	$	(33,588	)	$	(384	)	$	74,683
Share-Based Compensation		—		—		478			—		—			—			478
Employee Option Exercises		5,746		—		52			—		—			—			52
Restricted Stock Awards Vested, net		48,299		3		(3	)		—		(208	)		—			(208	)
Net Income		—		—		—			593		—			—			593
Other Comprehensive Loss		—		—		—			—		—			(65	)		(65	)

Balance May 1, 2021		10,479,139	$	524	$	58,576		$	50,678	$	(33,796	)	$	(449	)	$	75,533

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)


	Three Months Ended
	May 1, 2021			May 2, 2020
Cash Flows from Operating Activities:
Net Income	$	593		$	432
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization		1,425			1,568
Amortization of Debt Issuance Costs		25			12
Share-Based Compensation		478			495
Changes in Assets and Liabilities:
Accounts Receivable		2,165			1,220
Inventories		568			1,237
Income Taxes		(387	)		(90	)
Accounts Payable and Accrued Expenses		(552	)		(1,140	)
Other		(406	)		(314	)

Net Cash Provided by Operating Activities		3,909			3,420
Cash Flows from Investing Activities:
Additions to Property, Plant and Equipment		(544	)		(626	)

Net Cash Used for Investing Activities		(544	)		(626	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans		34			6
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan		18			26
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock		(208	)		(54	)
Borrowings under Revolving Credit Facility		—			5,000
Payment of Minimum Guarantee Royalty Obligation		(500	)		(500	)
Proceeds from Long-Term Debt Borrowings		10,000			—
Payoff of Long-Term Debt		(12,576	)		—
Principal Payments on Long-Term Debt		(187	)		—
Dividends Paid		—			(497	)

Net Cash Provided by (Used) for Financing Activities		(3,419	)		3,981

Effect of Exchange Rate Changes on Cash and Cash Equivalents		29			67

Net Increase (Decrease) in Cash and Cash Equivalents		(25	)		6,842
Cash and Cash Equivalents, Beginning of Period		11,439			4,249

Cash and Cash Equivalents, End of Period	$	11,414		$	11,091

Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	$	115		$	124
Cash Paid During the Period for Income Taxes, Net of Refunds	$	131		$	128

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad r

nge of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries

Our business consists of two

segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel®, TrojanLabel® and GetLabels™ brand names. The T&M segment includes our line of aerospace printers and test and measurement data acquisition systems sold under the AstroNova® brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers, high-volume presses and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, allowing customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats.

Our Product Identification products are sold by direct field salespersons as well as independent dealers and representatives, while our Test & Measurement products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in Product Identification products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.

Unless otherwise indicated, references to “AstroNova”, “we,” “our,” and “us” in this Quarterly Report on

Form 10-Q

refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information, in context of the unknown future impacts of

COVID-19

using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, accrued expenses, self-insurance liability accrual and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope and severity of the

COVID-19

pandemic. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

Table of Contents

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Note 2 – Summary of Significant Accounting Policies Update

The accounting policies used in preparing the condensed consolidated financial statements in this Form

10-Q

are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the FASB issued an ASU

2019-12,

“Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU

2019-12

is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. We adopted ASU

2019-12

for the period beginning February 1, 2021. The adoption of this guidance did not have a material impact on our consolidated financial statements and accompanying disclosures.

No other new accounting pronouncements, issued or effective during the three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:


	Three Months Ended
(In thousands)	May 1, 2021		May 2, 2020

United States	$	16,693	$	19,789
Europe		8,599		7,450
Canada		1,546		1,428
Asia		1,085		1,009
Central and South America		760		954
Other		395		289
Total Revenue	$	29,078	$	30,919

Major product types:


	Three Months Ended
(In thousands)	May 1, 2021		May 2, 2020

Hardware	$	7,647	$	8,914
Supplies		18,211		19,118
Service and Other		3,220		2,887
Total Revenue	$	29,078	$	30,919

Table of Contents

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.

Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $330,000 and $285,000 at May 1, 2021 and January 31, 2021, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The increase in the deferred revenue balance during the three months ended May 1, 2021

is primarily due to cash payments received in advance of satisfying performance obligations in the current period, offset by $

127,000

revenue recognized during the period that was included in the deferred revenue balance at January 31, 2021.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized based on the forecasted number of units sold over the remaining benefit term, which we currently estimate to be approximately 5 years. The balance of these contract assets at January 31, 2021 was $917,000. We amortized $9,000 of direct costs for the three months ended May 1, 2021 and the balance of deferred incremental direct costs net of accumulated amortization at May 1, 2021 was $908,000, of which $74,000 is reported in other current assets and $834,000 is

reported in other assets in the accompanying condensed consolidated balance sheet.

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period.

A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:


	Three Months Ended
	May 1, 2021		May 2, 2020


Weighted Average Common Shares Outstanding – Basic		7,144,697		7,073,278
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		120,632		31,365
Weighted Average Common Shares Outstanding – Diluted		7,265,329		7,104,643

For the three months ended May 1, 2021 and May 2, 2020, the diluted per share amounts do not reflect common equivalent shares outstanding of 622,020 and 865,157,

respectively, because of their anti-dilutive effect.

Table of Contents

Note 5 – Intangible Assets

Intangible assets are as follows:


	May 1, 2021									January 31, 2021
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(2,342	)	$	—	$	758	$	3,100	$	(2,284)		$	—	$	816
RITEC:
Customer Contract Relationships		2,830		(1,507	)		—		1,323		2,830		(1,423	)		—		1,407
TrojanLabel:
Existing Technology		2,327		(1,497	)		186		1,016		2,327		(1,405	)		196		1,118
Distributor Relations		937		(422	)		84		599		937		(396	)		89		630
Honeywell:
Customer Contract Relationships		27,243		(10,443	)		—		16,800		27,243		(9,712	)		—		17,531

Intangible Assets, net	$	36,437	$	(16,211	)	$	270	$	20,496	$	34,437	$	(15,220	)	$	285	$	21,502

There were

no impairments to intangible assets during the periods ended May 1, 2021 and May 2, 2020.

With respect to the acquired intangibles included in the table above, amortization expense of $1.0

million has been included in the condensed consolidated statements of income for each of the three months ended May 1, 2021 and May 2, 2020.

Estimated amortization expense for the next five fiscal years is as follows:


(In thousands)	Remaining 2022		2023		2024		2025		2026

Estimated amortization expense	$	2,968	$	3,976	$	4,075	$	3,420	$	3,026

Note 6 – Inventories

Inventories are stated at the lower of cost

(first-in,

first-out)

and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	May 1, 2021			January 31, 2021
Materials and Supplies	$	19,553		$	20,265
Work-In-Process		1,989			2,076
Finished Goods		16,641			16,371

		38,183			38,712
Inventory Reserve		(8,709	)		(8,652	)

	$	29,474		$	30,060

Table of Contents

Note 7 – Credit Agreement and Debt

On March 24, 2021, we entered into a First Amendment to Credit Agreement (the “Amendment”) to our Amended & Restated Credit Agreement (the “A&R Credit Agreement,” as amended by the Amendment; the “Amended Credit Agreement”) with Bank of America, N.A., as lender (the “Lender”), and our subsidiaries, ANI ApS and TrojanLabel. The A&R Credit Agreement, which we entered into on July, 30, 2020, amended and restated the Credit Agreement dated as of February 28, 2017 (the “Prior Credit Agreement”) by and among us, ANI ApS, TrojanLabel and the Lender. Immediately prior to the closing of the Amendment, we repaid

2.6

million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $

10.0

million and

amount drawn and outstanding under the revolving credit facility under the A&R Credit Agreement.

The Amended Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million, and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amendment, we borrowed the entire $10.0 million term loan which was used to refinance, in full, the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

The Amended Credit Agreement r

quires that the term loan be paid as follows: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2021 through January 31, 2022 is $187,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2022 through January 31, 2023 is $250,000; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2023 through January 31, 2025 is $312,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2025 and July 31, 2025 is $500,000; and the entire remaining principal balance of the term loan is required to be paid on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain

thresholds and conditions, without premium or penalty.

The Amended Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10.0 million, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

The interest rates under the A&R Credit Agreement were modified in the Amended Credit Agreement as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the LIBOR Rate as defined in the Amended Credit Agreement (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the LIBOR Rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30%

based on our

consolidated leverage ratio.

As under the A&R Credit Agreement, the loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

We must comply with various customary financial and

non-financial

covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Amendment.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Table of Contents

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	May 1, 2021			January 31, 2021
USD Term Loan (2.60% as of May 1, 2021); maturity date of September 30, 2025	$	9,813		$	—
USD Term Loan (4.65% as of January 31, 2021) maturity date of June 15, 2022		—			12,576

	$	9,813		$	12,576
Debt Issuance Costs, net of accumulated amortization		(116	)		(141	)
Current Portion of Term Loans		(813	)		(5,326	)

Long-Term Debt	$	8,884		$	7,109

During the three months ended May 1, 2021 and May 2, 2020, we recognized $115,000 and $79,000 of interest expense, respectively, which was included in other income (expense) in the accompanying condensed consolidated income statement.

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of May 1, 2021 is as follows:


(In thousands)
Fiscal 2022, remainder	$	563
Fiscal 2023		1,000
Fiscal 2024		1,000
Fiscal 2025		1,250
Fiscal 2026		6,000

	$	9,813

Note 8 – Paycheck Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”) which was enacted on June 5, 2020.

The PPP Loan, which will mature on May 6, 2022, is unsecured and bears interest at a rate of 1.0% per annum, accruing from the loan date, and is payable monthly. No

payments are due on the PPP Loan until the date on which the SBA determines the amount of the PPP Loan that is eligible for forgiveness, so long as we apply for forgiveness within the ten months from the end of the twenty-four week period following the date of loan disbursement, but interest will continue to accrue during the deferral period. We have accrued interest for the PPP Loan in the amount of

$11,000, which is included in other expense in the accompanying condensed consolidated statements of income for the three month period ended May 1, 2021. A total of $44,000

of interest has been accrued on the PPP Loan and is included in other liabilities and accrued expenses in the accompanying condensed consolidated balance sheet as of May 1, 2021.

Table of Contents

The PPP Loan may be prepaid at any time without penalty. The loan agreement and promissory note include customary provisions for a loan of this type, including prohibitions on our payment of dividends or repurchase of shares of our stock while the PPP Loan remains outstanding. The loan agreement and promissory note also include events of default relating to, among other things, payment defaults, breaches of the provisions of the loan agreement or the promissory note, and cross-defaults on other loans.

Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act, and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan may be forgiven in an amount up to the amount of the PPP Loan proceeds that we spent on payroll, rent, utilities and interest on certain debt during the twenty-four-week period following incurrence of the PPP Loan. Interest accrued on the forgiven portion of the principal amount of the PPP Loan is also forgiven. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40%

of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. We have fully utilized the PPP Loan proceeds for qualifying expenses during fiscal year 2021 and in the first quarter of this current year we have applied for forgiveness of the PPP Loan (including all associated accrued interest) in accordance with the terms of the CARES Act, as amended by the PPP Flexibility Act. Whether our application for forgiveness will be granted and in what amount is subject to approval by the SBA and may also be subject to further requirements in any regulations and guidelines the SBA may adopt. The PPP Loan is classified as long-term debt in the condensed consolidated balance sheet until the

forgiveness determination has been made by the SBA.

Note 9 – Derivative Financial Instruments and Risk Management

In 2017, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with our variable rate term loan borrowing. Both swaps were designated as cash flow hedges of floating-rate borrowings.

Our cross-currency interest rate swap agreement effectively modified our exposure to interest rate risk and foreign currency exchange rate risk by converting our floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement eff

ctively modified our exposure to interest rate risk by effectively converting our floating-rate term-loan debt to fixed-rate debt, thus reducing the impact of interest-rate changes on future interest expense. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan.

As a direct result of the terms of the Lender’s conditions for entry into the A&R Credit Agreement, on July 30, 2020, we terminated these two swaps. The terms of the A&R Credit Agreement caused those swaps to cease to be effective hedges of the underlying exposures.

The termination of the swaps was contracted immediately prior to the end of the second quarter of fiscal 2021 at a cash cost of approximately

0.7

million which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $

58,000

in accumulated other comprehensive loss related to the cross-currency interest rate swap was reclassified into earnings as the forecasted foreign currency interest payments will not occur. The remaining balance in accumulated other comprehensive loss related to the interest rate swap of $

0.2

million is being amortized into earnings through the original term of the hedge relationship as the underlying floating interest rate debt still exists.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three months ended May 1, 2021 and May 2, 2020:


	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative					Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	May 1, 2021		May 2, 2020					May 1, 2021			May 2, 2020
Swap contracts	$	—	$	(58	)		Other Expense	$	(20	)	$	43

At May 1, 2021, we expect to reclassify approximately $0.1 million of net losses on the frozen OCI balance associated with the terminated interest rate swap from accumulated other comprehensive loss to earnings during the next 12 months due to the payment of variable interest associated with the floating interest rate debt.

Table of Contents

Note 10 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement with Honeywell International, Inc. (“Honeywell”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years, based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated

after-tax

cost of debt for similar companies. As of May 1, 2021, we had paid an aggregate of $6.0 million of the guaranteed minimum royalty obligation. At May1, 2021, the current portion of the outstanding guaranteed minimum royalty obligation of $2.0 million is to be paid over the next twelve months and is reported as a current liability and the remainder of $5.7 million is reported as a long-term liability on our condensed consolidated balance sheet. We did not incur any excess royalty expense for the three month period ended May 1, 2021. A total of $0.2

million in excess royalties was paid in the first quarter of the current fiscal year and there are no excess royalty payables due as a result of this agreement for the period ended May 1, 2021.

Note 11 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of 1 to 6 years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:


Operating Leases (In thousands)	Balance Sheet Classification		May 1, 2021		January 31, 2021
Lease Assets		Right of Use Assets	$	1,302	$	1,389
Lease Liabilities – Current		Other Liabilities and Accrued Expenses		366		372
Lease Liabilities – Long Term		Lease Liabilities		983		1,065

Lease cost information is as follows:


		Three Months Ended
Operating Leases (In thousands)	Statement of Income Classification	May 1, 2021		May 2, 2020
Operating Lease Costs	General and Administrative Expense	$	136	$	120

Maturities of operating lease liabilities are as follows:


(In thousands)	May 1, 2021
2022, remaining	$	279
2023		317
2024		290
2025		182
2026		162
Thereafter		267

Total Lease Payments		1,497
Less: Imputed Interest		(148	)

Total Lease Liabilities	$	1,349

As of May 1, 2021, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 5.0 years and 4.0%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Table of Contents

Supplemental cash flow information related to leases is as follows:


	Three Months Ended
(In thousands)	May 1, 2021		May 2, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	92	$	106

Note 12 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2021	$	(275	)	$	(109	)	$	(384	)
Other Comprehensive Loss before reclassification		(81	)		—			(81	)
Amounts reclassified from AOCL to Earnings		—			16			16

Other Comprehensive Income (Loss)		(81	)		16			(65	)

Balance at May 1, 2021	$	(356)		$	(93	)	$	(449	)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German and Danish subsidiaries.

Note 13 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (“RSAs”). The 2018 Plan

uthorizes the issuance of up to

950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018

Plan, there were

145,534

unvested RSUs; 75,926 unvested PSUs; 48,000 unvested RSAs and options to purchase an aggregate of

135,500

shares outstanding as of May 1, 2021.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of May 1, 2021, options to purchase an aggregate of 327,418 shares were outstanding under the 2007 Plan and 3,750

unvested RSUs and options to purchase an aggregate of

141,375

were outstanding under the 2015 Plan.

We also have a

Non-Employee

Director Annual Compensation Program (the “Program”), under which each of our

non-employee

directors automatically receives a grant of restricted stock on the date of their

re-election

to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2022 is $60,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

Table of Contents

Share-based compensation expense was recognized as follows:


	Three Months Ended
(In thousands)	May 1, 2021		May 2, 2020

Stock Options	$	105	$	133
Restricted Stock Awards and Restricted Stock Units		370		357
Employee Stock Purchase Plan		3		5
Total	$	478	$	495

Stock Options

There were no stock options granted during the three months ended May 1, 2021 and May 2, 2020.

Aggregated information regarding stock option activity for the three months ended May 1, 2021 is summarized below:


	Number of Options			Weighted Average Exercise Price

Outstanding at January 31, 2021		622,083		$	14.63
Granted		—			—
Exercised		(3,775	)		8.84
Forfeited		(14,015	)		14.96
Canceled		—			—

Outstanding at May 1, 2021		604,293		$	14.66

Set forth below is a summary of options outstanding at May 1, 2021:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$5.00-10.00		37,244	$	7.97		1.2		37,244	$	7.97		1.2
$10.01-15.00		349,299	$	13.62		4.6		337,299	$	13.61		4.5
$15.01-20.00		217,750	$	17.47		6.6		165,492	$	17.21		6.4

		604,293	$	14.66		5.1		540,035	$	14.32		4.9

As of May 1, 2021, there was approximately $0.1 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 0.7 years.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU and RSA activity for the three months ended May 1, 2021 is summarized below:


	RSAs & RSUs			Weighted Average Grant Date Fair Value

Outstanding at January 31, 2020		197,413		$	9.96
Granted		124,096			14.26
Vested		(48,299	)		10.26
Forfeited		—			—

Outstanding at May 1, 2021		273,210		$	11.86

As of May 1, 2021, there was approximately $2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.1 years.

Table of Contents

Employee Stock Purchase Plan

We have an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the three months ended May 1, 2021 and May 2, 2020, there were 1,813 and 3,755 shares, r

spectively, purchased under this plan.

As of May 1, 2021,

8,561

shares remain available for purchase under our Employee Stock Purchase Plan.

Note 14 – Income Taxes

Our effective tax rates are as follows:


	First Quarter Ended

Fiscal 2022		(62.0	)%
Fiscal 2021		(37.6	)%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted

pre-tax

income and facts known at that time. The estimated annual effective tax rate is applied to the

year-to-date

pre-tax

income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended May 1, 2021, we recognized an income tax benefit of approximately $227,000. The effective tax rate in this period was directly impacted by a $276,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $37,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended May 2, 2020, we recognized an income tax benefit of approximately $118,000. The effective tax rate in this period was directly impacted by a reduction in forecasted operating results for fiscal 2021 and a $78,000 tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of May 1, 2021, our cumulative unrecognized tax benefits totaled $221,000 compared to $384,000 as of January 31, 2021. Besides the expiration of the statute of limitations on a previously uncertain tax position, there were no

other developments affecting unrecognized tax benefits during the quarter ended May 1, 2021.

Note 15 – Segment Information

We report two segments: Product Identification (“PI”) and Test & Measurement (“T&M”). We evaluate segment performance based on the segment profit (loss) before corporate expenses.

Table of Contents

Summarized below are the Revenue and Segment Operating Profit (Loss) for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit (Loss)
(In thousands)	May 1, 2021		May 2, 2020		May 1, 2021			May 2, 2020
Product Identification	$	23,098	$	22,380	$	2,729		$	3,146
T&M		5,980		8,539		350			(156	)

Total	$	29,078	$	30,919		3,079			2,990

Corporate Expenses						2,344			2,327

Operating Income						735			663
Other Expense, Net						369			349

Income Before Income Taxes						366			314
Income Tax Benefit						(227	)		(118	)

Net Income					$	593		$	432

Note 16 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	May 1, 2021
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	9,821	$	9,821	$	9,813

Table of Contents


	January 31, 2021
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	12,586	$	12,586	$	12,576

The above table does not include the PPP loan, as the fair value of the PPP loan approximates its carrying value.

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with our condensed consolidated financial statements included elsewhere herein and our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

We are a multinational enterprise that leverages our proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. We organize our structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. We market and sell our products and services through the following two segments:

•

Product Identification (“PI”) – offers color and monochromatic digital label printers,

direct-to-package

printers and custom OEM printers. PI also provides software to design, manage and print labeling and packaging images locally and across networked printing systems, as well as all related printing supplies such as pressure sensitive labels, tags, inks, toners and thermal transfer ribbons used by digital printers. PI also provides

on-site

and remote service, spare parts and various service contracts.

•

Test and Measurement (“T&M”) – offers a suite of products and services that acquire data from local and networked data streams and sensors as well as wired and wireless networks. The T&M segment includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft including navigation maps, clearances, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Aerospace products also include aircraft networking systems for high-speed onboard data transfer. T&M also provides repairs, service and spare parts.

We market and sell our products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets. Our growth strategy centers on organic growth through product innovation made possible by research and development initiatives, as well as strategic acquisitions that fit into or complement existing core businesses.

COVID-19

Update—Overview

Our business has been materially adversely affected by the global

COVID-19

pandemic. We operate in several regions of the world, with the largest concentration of team members in North America and Europe, and a small presence in Asia. Throughout the pandemic we, and many other businesses and other organizations with which we do business directly or which otherwise impact us, have taken and are continuing to take steps to avoid or reduce infection as recommended by the public health authorities, including working remotely from home and limiting business travel . Although travel restrictions between regions have recently loosened to a limited degree, many restrictions still remain in place, especially in Europe, and it is too early to determine the precise impact that the recent relaxation of restrictions will have our business. Additionally, while vaccine availability and inoculation rates have had a favorable impact and, as a result, most public health authorities in the United States and Asia have determined that the quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures that have been implemented as a result of the pandemic are no longer necessary, this is not uniformly accepted and we have not determined exactly how our own business practices and those of with whom we do business, will change as a result.

Table of Contents

Since the

COVID-19

pandemic began, we have monitored government recommendations and regulations and made good faith efforts to comply with those regulations and the best practices recommendations issued by a variety of governmental health authorities and manufacturing industry organizations to which we belong. We have also made significant modifications to our normal operations because of the

COVID-19

pandemic, including requiring most

non-production

related team members to work remotely, at least part-time. At this time, most of these measures will continue to remain in place for the near term, although we do plan to relax some of them in response to the recent governmental relaxation of restrictions, we do not know when, or if it will become practical to relax or eliminate some, or all of these measures altogether. Since the start of the pandemic, we have maintained most of manufacturing operational capacity at our facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany. In the West Warwick and Canadian operations there were periods when a number of team members were unable to keep work schedules due to the effects of the pandemic, which resulted in reduced production capacity that led to longer order fulfillment lead times and as a result, reduced revenues. While those issues have largely abated, they are still impacting our operations in Germany. The extent to which the

COVID-19

pandemic continues to negatively impact our manufacturing production will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity

of COVID-19 associated

variants, the continued efficacy of vaccinations and the willingness of our employees and others to become vaccinated, among others. We expect that our operations and modalities of

on-site

and remote work will be impacted permanently, as will our increased safety protocols and the other adaptations undertaken during the pandemic, but we are still developing our plans and cannot predict the result yet.

During the

COVID-19

pandemic, we have experienced some difficulties in obtaining raw materials and components for our products. As the pandemic has begun to abate, some of the structural dislocations in the global economy that resulted are prolonging these difficulties. We have been able to recover from these difficulties, but we have had to incur some additional costs in expedited and express shipping fees. These difficulties have impacted our efficiency and our ability to satisfy customer requirements, but we do not believe that they have materially impacted our financial results or our relationships with our customers. We are currently monitoring the world-wide delays in transit time, as freight carriers are now experiencing significant delays in overseas shipments. We are addressing these issues through long range planning and supplementing inventories as needed. We are also in particular monitoring the extended lead times on active electronic components and utilizing several strategies, including blanket orders, vendor-bonded inventories, extended commitments to our supply base, and seeking alternative suppliers. Additionally, we have taken actions to maintain regular contact with our important vendors and have increased our forecasting horizon for our products to help us better manage our supply chain. Our strategies to counteract the impact of the pandemic have tended to increase the amount of inventory we maintain, but because of the complexity of our supply chain, it is impossible to isolate the precise impact of each element. We will continue to monitor our supply chain going forward and update our mitigation strategies as we determine appropriate. While we are not able to predict what the full impact of the current supply chain difficulties even as the

COVID-19

pandemic starts to winds down, if we the steps we are taking are not effective, it could have a material adverse impact on our results of operations.

It is not possible at this time to estimate the how the continued development of the recovery from the

COVID-19

pandemic itself or the consequences of its aftermath will impact our business, customers, suppliers or other business partners, and the degree it will adversely change our operational capacity and the efficiency of our team members or affect our results of operations and financial condition.

Table of Contents

Product Identification Update

The global

COVID-19

pandemic has also negatively impacted sales of our Product Identification hardware products primarily as a result of the impact of travel restrictions on our sales efforts, as most customers historically have preferred

in-person

demonstrations of these printers at their production sites prior to placing orders with us and those visits have been severely limited. Additionally, the widespread cancellation of trade shows, which traditionally provided an effective forum for customers to consider our products, has also had an adverse impact on traditional methods of sales lead generation. However, we believe we have been able to partially offset these negative impacts by placing a greater reliance on various forms of digital advertising and internet-based marketing techniques, including remote video demonstrations and support, which has proven effective in obtaining sales. Despite favorable market reception to our recently refreshed and expanded product lines, the degree to which we will be able to maintain or grow the level of hardware revenues through the changes we have made to our

go-to-market

strategies remains unclear. As the

COVID-19

pandemic abates, and it becomes possible for our direct sales force and distributors to travel to visit customers and attend and present products at trade shows (if they are even offered), it is likely that some reversion to those historical sales methods will occur, but some of the

COVID-19

induced adaptations are also likely to become permanent. At this time however, we do not know how that mix of sales strategies will evolve and how they will impact the results of operations for this segment.

Despite the pandemic, underlying overall demand remained strong through this period and in general, we believe that the diversified nature of our end markets and the relative concentration of business in consumer

non-durable

market related applications impart a greater degree of near- and longer-term stability to our Product Identification segment.

Test & Measurement Update

Our sales of flight deck printers for Boeing 737 aircraft have been severely impacted by the chain of events that occurred after two 737 MAX aircraft crashed. In March 2019, all major civil aviation authorities worldwide grounded the Boeing 737 MAX aircraft for safety reasons. In April 2019, Boeing reduced the number of 737 MAX aircraft produced per month from 52 to 42, and in January 2020, Boeing ceased production of the 737 MAX completely. On May 27, 2020, in anticipation of an eventual certification, Boeing announced that it would

re-start

production at low initial rates and gradually increase production in the future.

On August 3, 2020, the United States Federal Aviation Administration (the “FAA”) issued a notice of proposed rulemaking for a Boeing 737 MAX airworthiness directive, and on November 18, 2020 the FAA certified the model for return to service in the United States. On January 27, 2021, the European Union Aviation Safety Agency (EASA) approved the return to service of the Boeing 737 MAX in Europe. The exact timing of

re-certification

by other worldwide civil aviation authorities is unknown but we expect that most will permit a return to service later in 2021. Before any individual 737 MAX aircraft can return to commercial service, all civilian aviation authority agency certification requirements relevant to each carrier must be met. As these requirements vary, and can be quite extensive, the exact timing of the recertification and return to service of the 737 MAX fleet in each geographical area is unclear at this time and will depend on the ability of Boeing and each airline to complete the required steps.

Aircraft manufacturing rather than aircraft deliveries primarily drives demand for our airborne printer products. We have experienced very low levels of 737 MAX new printer orders and shipments since the production halt, as Boeing is now producing a small number of new aircraft per month. The majority of our future 737 MAX printer sales volume will be tied to the pace of Boeing’s manufacturing dates and delivery schedules, and the pace of the recovery in their production rates is uncertain and will likely be prolonged. We believe that Boeing has already installed our printers in most of the airplanes that it has completed and that require our printers to be installed prior to delivery. Though we have noted that some airlines are now ordering new 737 MAX aircraft again, and we have seen slight increases in orders for future delivery, the effect of the improving outlook and its timing remains unknown. The precipitous decline in global air travel demand and resultant reduction in the number of flights scheduled by airlines caused by the pandemic has begun to recover, but order demand from airlines for new deliveries of most aircraft models remains far below

pre-pandemic

levels. As the

COVID-19

pandemic impact on the air travel industry abates, the financial health of the airlines and airframe manufacturers is likely to remain stressed for some time, and the ultimate impact on the structure of the industry and the individual companies that comprise it is unknown. Because we are the primary source for aircraft cabin printers to the airframe manufacturers for a majority of aircraft models produced in the world, the longer-term demand for our products is defined less by the impact of

COVID-19

on particular airlines within the industry than the health of the industry as a whole. Although we do not know what the timing and rate of recovery will be, we do expect that the industry, and hence the demand for our products, will continue to recover slowly as the impact of effective vaccines become both widely available and accepted globally, and as demand for air travel recovers.

Demand for aerospace spare products, paper, parts and repairs has also been significantly impacted by the decline in air travel, as requirements for these products and services are based primarily upon aircraft usage. Although we have experienced modest increases in demand for spare products, paper, parts and repairs as flight hours have increased since the second quarter of fiscal 2021, we do not know the degree to which this will continue or increase, or at what pace.

Table of Contents

While we have reduced our costs as much as we are prudently able to, our strategy and operational plans are to maintain sufficient capabilities and staffing to fully support our customers and meet the stringent quality requirements the market requires, and to be able to rapidly increase production as demand returns, the decline in revenue has adversely impacted our profitability.

Results of Operations

Three Months Ended May 1, 2021 vs. Three Months Ended May 2, 2020

Revenue by segment and current quarter percentage change over the prior year for the three months ended May 1, 2021 and May 2, 2020 were:


(Dollars in thousands)	May 1, 2021		As a % of Revenue			May 2, 2020		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	23,098		79.4	%	$	22,380		72.4	%		3.2	%
T&M		5,980		20.6	%		8,539		27.6	%		(30.0	)%

Total	$	29,078		100.0	%	$	30,919		100.0	%		(6.0	)%

Revenue for the first quarter of the current year was $29.1 million, representing a 6.0% decrease compared to the previous year first quarter revenue of $30.9 million. Revenue through domestic channels for the first quarter of the current year was $16.7 million, a decrease of 3.2% from the prior year’s first quarter. International revenue for the first quarter of the current year was $12.4 million, representing 42.6% of our first quarter revenue and reflecting an 11.3% increase from the previous year first quarter. Current year first quarter international revenue includes a favorable foreign exchange rate impact of $0.8 million.

Hardware revenue in the current quarter was $7.6 million, a 14.2% decrease compared to the prior year’s first quarter revenue of $8.9 million. The decrease is attributable to the T&M segment, as hardware revenue for that segment decreased 39.2% compared to the first quarter of the prior year. The T&M decrease in segment hardware sales resulted primarily from decreased aerospace printer product line sales. The decline in current quarter hardware sales was partially offset by an overall 42.4% increase in hardware sales in the PI segment, as well as an overall increase in sales of data recorders in the T&M product group.

Supplies revenue in the current quarter was $18.2 million, a 4.7% decrease compared to the prior year’s first quarter supplies revenue of $19.1 million. The decrease is primarily attributable to lower ink jet and thermal film supplies revenue in the PI segment. The overall decrease in supplies revenue was also impacted to a lesser degree by a decline supplies revenue in the T&M segment primarily related to declines in sales of printer supply products in the aerospace product group. The decline in supply revenue was slightly offset by increased sales of Trojan Label product group ink supplies in the Product Identification segment.

Service and other revenues of $3.3 million in the current quarter increased 11.5% compared to first quarter revenue of $2.9 million in the prior year. The increase is due primarily to increased parts and repair revenue in the Product Identification segment, as well as smaller increases in parts and repair revenue in the T&M segment.

Current year first quarter gross profit was $10.9 million, consistent with the prior year’s first quarter gross profit despite the lower revenue. Current quarter gross profit margin of 37.4% reflects a 2.3 percentage point increase from the prior year’s first quarter gross profit margin of 35.1%. The higher gross profit margin for the current quarter compared to the prior year’s first quarter is primarily attributable to lower manufacturing and period costs.

Operating expenses for the current quarter were $10.2 million, consistent with the prior year’s first quarter operating expenses. Current quarter selling and marketing expenses were $6.1 million, a 2.8% increase compared to the first quarter of the prior year. The increase for the current quarter was primarily due to slight increases in employee wage and commission expenses, and outside service expenditures, offset to a large degree by decreased employee benefits expense. Current quarter general and administrative expenses were $2.3 million, comparable to the first quarter of the prior year. Research and development (“R&D”) expenses were $1.7 million in the current quarter, an 11.5% decrease compared to $1.9 million in the first quarter of the prior year primarily due to decreases in employee wage and benefits and expenses. R&D spending as a percentage of revenue for the current quarter was 5.9% as compared to 6.3% for the same period in the prior year.

Other expense in the first quarter of the current year was $0.4 million, consistent with the first quarter of the prior year. Current quarter other expense includes interest expense on debt and the PPP loan of $0.2 million and $0.2 million of net foreign exchange loss. Other expense for the first quarter of the prior year also consisted primarily of interest expense on our debt and revolving line of credit of $0.2 million and $0.2 million of net foreign exchange loss.

Table of Contents

We recognized a federal, state and foreign income tax benefit for the first quarter of the current year of $227,000, resulting in a negative effective tax rate of 62.0%. This rate was impacted by a $276,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $37,000 tax benefit arising from windfall tax benefits related to the Company’s stock. This compares to the prior year’s first quarter income tax benefit of $118,000, with a resulting negative effective tax rate of 37.6%. This rate was impacted by a reduction in internally forecasted operating results for our fiscal 2021 and a $78,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions.

We reported net income of $0.6 million or $0.08 per diluted share for the first quarter of the current year. On a comparable basis, net income for the prior year’s first quarter was $0.4 million or $0.06 per diluted share. Return on revenue was 2.0% for the first quarter of fiscal 2022 compared to 1.4% for the first quarter of fiscal 2021.

Segment Analysis

We report two segments: Product Identification and Test & Measurement and evaluate segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit (Loss) for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit (Loss)
(In thousands)	May 1, 2021		May 2, 2020		May 1, 2021			May 2, 2020
Product Identification	$	23,098	$	22,380	$	2,729		$	3,146
T&M		5,980		8,539		350			(156	)

Total	$	29,078	$	30,919		3,079			2,990

Corporate Expenses						2,344			2,327

Operating Income						735			663
Other Expense, Net						369			349

Income Before Income Taxes						366			314
Income Tax Benefit						(227	)		(118	)

Net Income					$	593		$	432

Product Identification

Revenue from the Product Identification segment increased 3.2% in the first quarter of the current year, with revenue of $23.1 million compared to $22.4 million in the same period of the prior year. The current quarter increase in revenue is due to a net increase in hardware revenue, aided by strong sales of the new TrojanLabel

T3-OPX

printer. Product Identification’s current quarter segment operating profit was $2.7 million, reflecting a profit margin of 11.8%. This compares to the prior year’s first quarter segment profit of $3.1 million and related profit margin of 14.1%. The decrease in Product Identification current year first quarter segment operating profit and margin is primarily due to higher operating costs.

Test & Measurement—T&M

Revenue from the T&M segment was $6.0 million for the first quarter of the current fiscal year, representing a 30.0% decrease compared to revenue of $8.5 million for the same period in the prior year. The decrease in revenue for the current quarter is primarily attributable to the continued decline in sales of hardware in our aerospace product lines as a result of the Boeing 737 MAX grounding and also the severe drop in demand for new aircraft related to the dramatic decline in air travel due to the impact of

COVID-19.

T&M’s first quarter segment operating profit was $0.4 million, reflecting a profit margin of 5.9%, an increase compared to the prior year segment operating loss of $0.2 million and related negative operating margin of 1.8%. Despite lower sales revenue in the current quarter, the increase in segment operating profit and related margin were primarily due to lower period and operating costs, along with slightly better sales mix.

Table of Contents

Financial Condition and Liquidity

Overview

Historically, our primary sources of short-term liquidity have been cash generated from operating activities and borrowings under our revolving credit facility. These sources have also usually funded the majority of our capital expenditures and contractual contingent consideration obligations. We have funded acquisitions by borrowing under bank term loan facilities.

On July 30, 2020, we entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with the Bank of America, N.A. (the “Lender”), our wholly owned subsidiary ANI ApS, a Danish private limited liability company and ANI ApS’s wholly-owned subsidiary TrojanLabel ApS, a Danish private limited liability company (“TrojanLabel”). The A&R Credit Agreement amended and restated the Credit Agreement dated as of February 28, 2017 by and among us, ANI ApS, TrojanLabel and the Lender. In connection with our entry into the A&R Credit Agreement, we entered into an Amended and Restated Security and Pledge Agreement and a mortgage in favor of the Lender with respect to our owned real property in West Warwick, Rhode Island. Under the A&R Credit Agreement, AstroNova, Inc. is the sole borrower, and its obligations are guaranteed by ANI ApS and TrojanLabel.

On March 24, 2021, we entered into a First Amendment to Credit Agreement (the “Amendment”) to our A&R Credit Agreement (the “A&R Credit Agreement amended by the Amendment, the “Amended Credit Agreement”) with the Lender, ANI ApS and TrojanLabel. Immediately prior to the closing of the Amendment, we repaid $ 2.6 million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $10.0 million and no amount drawn and outstanding under the revolving credit facility under the Amended Credit Agreement.

The Amended Credit Agreement expires on September 30, 2025, a significant extension of tenor. It also eliminated a minimum adjusted EBITDA covenant, an asset coverage covenant and a minimum liquidity covenant, and, subject to ongoing covenant compliance, significantly reduced limitations on restricted payments such as dividends, eliminated restrictions on capital expenditures and increased operating flexibility with respect to funding our global operations.

Table of Contents

The Amended Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million, and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amended Credit Agreement, we borrowed the entire $10.0 million term loan which was used to refinance in full the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

While we have expected that as a result of the impact of the

COVID-19

pandemic, some of our customers would experience liquidity pressure and be unable to pay us for products on a timely basis, in general our recent receivables collection experience has been consistent with our historical experience and a significant deterioration in receivables collection has not occurred.

In response to the

COVID-19

pandemic and related economic dislocation, we have implemented and will continue to implement a variety of expense reduction and cash preservation initiatives. On April 27, 2020, our board of directors suspended our quarterly cash dividend beginning with the second quarter of our fiscal year 2021.

At May 1, 2021, our cash and cash equivalents were $11.4 million. There was no outstanding balance on our revolving line of credit at May 1, 2021 and we have $22.5 million available for borrowing under that facility. We believe that our available cash and credit facilities combined with our cash generated from operations will be sufficient to support our operating requirements, so long as the impact of

COVID-19

does not worsen.

Indebtedness

Term Loan

The Amended Credit Agreement requires that the term loan be paid as follows: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2021 through January 31, 2022 is $187,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2022 through January 31, 2023 is $250,000; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2023 through January 31, 2025 is $312,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2025 and July 31, 2025 is $500,000; and the entire remaining principal balance of the term loan is required to be paid on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The Amended Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10,000,000, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

The interest rates under the A&R Credit Agreement were modified in the Amended Credit Agreement as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the LIBOR Rate as defined in the A&R Credit Agreement (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the LIBOR Rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30% based on our consolidated leverage ratio.

We must comply with various customary financial and

non-financial

covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The minimum EBITDA, minimum consolidated asset coverage ratio, minimum liquidity and maximum capital expenditures covenants with which we were required to comply under the A&R Credit Agreement were eliminated

Table of Contents

by the Amendment. The primary

non-financial

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held by us in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island. Pursuant to the Amendment, the guarantees of our obligations under the A&R Credit Agreement that were previously provided by ANI ApS and TrojanLabel were released.

PPP Loan

On May 6, 2020, we entered into a Loan Agreement with and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”), which was enacted on June 5, 2020. We believe that our obtaining the PPP Loan and suspending the payment of dividends on our common stock were instrumental in our ability to successfully negotiate the A&R Credit Agreement.

The PPP Loan, which will mature on May 6, 2022, is unsecured and bears interest at a rate of 1.0% per annum, accruing from the loan date and is payable monthly. No payments are due on the PPP Loan at this time, but interest accrues during the deferral period. Interest accrued in the amount of $44,000 has been accrued through May 1, 2021.

The PPP Loan may be prepaid at any time without penalty. The Loan Agreement and Promissory Note include customary provisions for a loan of this type, including prohibitions on our payment of dividends or repurchase of shares of our stock while the PPP Loan remains outstanding and events of default relating to, among other things, payment defaults, breaches of the provisions of the Loan Agreement or the Promissory Note and cross-defaults on other loans.

Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan may be forgiven in an amount up to the amount of the PPP Loan proceeds we spent on payroll, rent, utilities and interest on certain debt during the twenty-four week period following incurrence of the PPP Loan; interest accrued on the forgiven portion of the principal amount of the PPP Loan is also forgiven. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40% of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. In fiscal 2021, we fully utilized the PPP Loan proceeds for qualifying expenses and have applied for forgiveness of the PPP Loan (including all associated accrued interest) in the first quarter of the current year. Whether our application for forgiveness will be granted and in what amount is subject to an application to, and approval by, the SBA and may also be subject to further requirements in any regulations and guidelines the SBA may adopt.

Cash Flow

Our statements of cash flows for the three months ended May 1, 2021 and May 2, 2020 are included on page 7 of this report. Net cash provided by operating activities was $3.9 million for the first three months of fiscal 2022 compared to $3.4 million for the same period of the previous year. The increase in net cash provided by operations for the first three months of the current year is primarily due to the increase in cash provided by working capital. The combination of changes in accounts receivable, inventory, income taxes payable, accounts payable and accrued expenses increased cash by $1.8 million for the first three months of fiscal 2022, compared to an increase of $1.2 million for the same period in fiscal 2021.

Our accounts receivable balance decreased to $15.2 million at the end of the first quarter compared to $17.4 million at year end. Days sales outstanding for the first quarter of the current year also declined to 47 days compared to 51 days at prior year end. The decline in the accounts receivable balance and days sales outstanding in the first quarter of the current year is largely due to the

Table of Contents

increase in PI product sales, which tend to have shorter collection cycles, as well as a few large payments received on account from aerospace customers.

The inventory balance was $29.5 million at the end of the first quarter of fiscal 2022, a small decline compared to $30.1 million at year end. Inventory days on hand decreased to 146 days at the end of the current quarter from 147 days at the prior year end.

Table of Contents

The cash position remained consistent with year end at $11.4 million. Cash was primarily provided from the working capital accounts, as discussed above. Cash outflows and during the quarter included the refinancing of debt, which resulted in a net outflow of cash of $2.6 million, principal payments on the new long-term debt and the guaranteed royalty obligation of $0.2 million and $0.5 million, respectively, and cash used to acquire property, plant and equipment of $0.5 million.

Contractual Obligations, Commitments and Contingencies

There have been no material changes to our contractual obligations as disclosed in our Annual Report on

Form 10-K

for the fiscal year ended January 31, 2021 other than those occurring in the ordinary course of business.

Critical Accounting Policies, Commitments and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly

re-evaluate

these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. There have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

Forward-Looking Statements

This Quarterly Report on Form

10-Q

may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) the impact of the ongoing

COVID-19

pandemic on us, our customers, our suppliers and the global economy; (c) declining demand in the test and measurement markets, especially defense and aerospace; (d) our ability to develop and introduce new products and achieve market acceptance of these products; (e) difficulties encountered in connection with the certification of the 737 MAX for return to service; (f) our dependance on contract manufactures and/or single or limited source suppliers; (g) competition in the specialty printer or data acquisition industries; (h) our ability to obtain adequate pricing for our products and control our cost structure; (i) our ability to adequately enforce and protect our intellectual property, defend against assertions of infringement or loss of certain licenses; (j) the risk of a material security breach of our information technology system or cybersecurity attack impacting our business and our relationship with customers; (k) any technology disruption or delay in implementing new technology or our new global ERP system; (l) our ability to attract, develop and retain key employees; (m) economic, political and other risks associated with international sales and operations and the impact of changes in foreign currency exchange rates on the results of operations; (n) changes in tax rates or exposure to additional income tax liabilities; (o) our ability to comply with our current credit agreement or secure alternative financing and to otherwise manage our indebtedness; (p) our ability to successfully integrate acquisitions and realize benefits from divestitures; (q) our ability to maintain adequate self-insurance accruals or insurance coverage for employee health care benefits; (r) our compliance with customer or regulators certifications and our compliance with certain governmental laws and regulations; and (s) other risks included under

“Item 1A-Risk

Factors” in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Table of Contents

Item

Quantitative and Qualitative Disclosures About Market Risk

During the three months ended May 1, 2021, there were no material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form

10-K

for the year ended January 31, 2021.

Item

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to

Rule 13a-15(b)

under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item

Legal Proceedings

There are no pending or threatened legal proceedings against us that we believe to be material to our financial position or results of operations.

Item

1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form

10-Q,

one should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form

10-K

for the fiscal year ended January 31, 2021, which could materially affect our business, financial condition or future operating results. The risks described in our Annual Report on

10-K

are not the only risks that could affect our business, as additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results as well as adversely affect the value of our common stock.

There have been no material updates to the risk factors previously disclosed in the Company’s Annual Report on

Form 10-K

for the fiscal year ended January 31, 2021.

Item

Unregistered Sales of Equity Securities and Use of Proceeds

During the first quarter of fiscal 2022, we made the following repurchases of our common stock:


	Total Number of Shares Repurchased			Weighted Average Price paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares That May Be Purchased Under the Plans or Programs
February 1—February 28		—		$	—			—		—
March 1—March 31,		15,629	(a)(b)	$	13.32	(a) (b)		—		—
April 1—April 30		—		$	—			—		—

Table of Contents

(a)

Executives of the Company delivered 7,287 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $12.31 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

(b)

Executives of the Company delivered 8,342 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $14.20 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

Table of Contents

Item

Exhibits


3A		Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.

3B		By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form 10-K/A for the fiscal year ended January 31, 2008 (File no. 000-13200) and incorporated by reference herein.

10.1		First Amendment to Credit Agreement dated as of March 24, 2021 among AstroNova, Inc. ANI ApS, TrojanLabel ApS and Bank of America, N.A., filed as Exhibit 10.34 to the Company’s Annual Report on Form 10-K for the period ended January 31, 2021 and incorporated by reference herein.

10.2		First Amendment to Open-End Mortgage Deed to Secure Present and Future Loans under Chapter 25 of Title 34 of the Rhode Island General Laws, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated as of March 24, 2021 among AstroNova, Inc. and Bank of America, N.A, filed as Exhibit 10.35 to the Company’s Annual Report on Form 10-K for the period ended January 31, 2021 and incorporated by reference herein.

31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

		101.SCH Inline XBRL Taxonomy Extension Schema Document

		101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

		101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document

		101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

		101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

		104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	ASTRONOVA, INC . (Registrant)

Date: June 10, 2021	By	/s/ Gregory A. Woods
		Gregory A. Woods,
		President and Chief Executive Officer
		(Principal Executive Officer)

	By	/s/ David S. Smith
		David S. Smith,
		Vice President, Chief Financial Officer and Treasurer
		(Principal Accounting Officer and Principal Financial Officer)